Zenas BioPharma (ZBIO) Change in Account Payables (2023 - 2026)

Zenas BioPharma's Change in Account Payables history runs 4 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• In Q1 2026, Change in Account Payables fell 37.72% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at -$11.1 million (down 199.24% YoY), while the FY2025 annual figure was -$10.0 million, down 185.55% from the prior year.
• Change in Account Payables was $1.8 million for Q1 2026 at Zenas BioPharma, up from $1.1 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $5.4 million in Q4 2024 to a low of -$12.1 million in Q2 2025.
• Historically, Change in Account Payables has averaged $661200.0 across 4 years, with a median of $2.3 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Change in Account Payables jumped 73.75% in 2024, then plunged 2418.12% in 2025.
• A 4-year view of Change in Account Payables shows it stood at $3.1 million in 2023, then surged by 73.75% to $5.4 million in 2024, then plunged by 79.41% to $1.1 million in 2025, then jumped by 60.84% to $1.8 million in 2026.
• The last three Change in Account Payables figures came in at $1.8 million (Q1 2026), $1.1 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.